News

ReacX Pharmaceuticals Initiates Nalmefene Phase I Clinical Study

By /

FOR IMMEDIATE RELEASE SOUTH SAN FRANCISCO, CA, UNITED STATES – January 21, 2026 — ReacX Pharmaceuticals, Inc., a clinical-stage pharmaceutical […]